NCT00864318 2026-04-14
TICE
Institut Claudius Regaud
Phase 2 Completed
Clinical Trials
5 trialsNCT01873326 2025-07-03
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT02414685 2020-08-07
TIP
National Cancer Institute, Slovakia
Phase 2 Completed
NCT00183820 2017-07-07
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
University of Southern California
Phase 2 Completed
NCT00611962 2008-02-11
Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin
Sanofi
Phase 2 Completed